SAVIMS

November 2022

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

FDA Oversight of Clinical Trials Criticised

Reference: Demasi, M. (2022). FDA oversight of clinical trials is “grossly inadequate,” say experts. BMJ, 379, o2628. http://doi.org/10.1136/bmj.o2628 Summary: Experts are raising alarms about the US Food and Drug Administration’s (FDA) oversight of clinical trials, particularly following the expedited development of Covid-19 vaccines. A complaint by Brook Jackson, a former employee at Ventavia Research Group, […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Current Knowledge on mRNA Vaccine Excretion and Potential Risks

Reference: Banoun, H. (2022). Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products. Infectious Diseases Research, 3(4), 22. https://doi.org/10.53388/IDR20221125022 Summary: The article examines the potential for excretion of mRNA and spike protein from COVID-19 mRNA vaccines,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccines, Viral illnesses

Natural Infection vs. mRNA Vaccination in COVID-19: Insights from Qatar

Reference: Chemaitelly, H., AlMukdad, S., Butt, A. A., Abu-Raddad, L. J., Ayoub, H. H., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Khal, A., Al-Thani, M.

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SARS-CoV-2 Spike Protein and Hemagglutination: A Study on COVID-19 Morbidities

Reference: Boschi, C., Scheim, D. E., Bancod, A., Millitello, M., Le Bideau, M., Colson, P., Fantini, J., & La Scola, B. (2022). SARS-CoV-2 spike protein induces hemagglutination: Implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects. bioRxiv. https://doi.org/10.1101/2022.11.24.517882 Summary: The study investigates how the SARS-CoV-2 spike protein facilitates hemagglutination (HA) in red blood

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over Pfizer’s COVID Vaccine and Immune System Impact

Reference: The Exposé. (2022, November 7). Pfizer’s clinical trial papers prove COVID vaccines destroy the immune system. https://expose-news.com/2022/11/07/pfizer-trial-proves-covid-vaccine-decimates-immune-system Summary: The Exposé article raises alarming concerns regarding Pfizer’s COVID-19 vaccine, citing data from its Phase I-III clinical trials. It reports that the sepsis death rate among double-vaccinated participants was twenty-one times higher than expected, while the

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

VAERS COVID-19 Vaccine Adverse Events Data

Reference: OpenVAERS. (2023). VAERS COVID-19 vaccine adverse events data. Retrieved from https://www.openvaers.com/covid-data Summary: The VAERS COVID-19 Vaccine Adverse Events Data provides a comprehensive overview of reported adverse events following COVID-19 vaccinations in the United States. The data is sourced from the Vaccine Adverse Event Reporting System (VAERS), which is a national system for monitoring the

Scroll to Top